Exact Mass: 540.3563
Exact Mass Matches: 540.3563
Found 329 metabolites which its exact mass value is equals to given mass value 540.3563
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ciclesonide
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ciclesonide
Ciclesonide is only found in individuals that have used or taken this drug. It is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco.Glucocorticoids such as ciclesonide can inhibit leukocyte infiltration at the site of inflammation, interfere with mediators of inflammatory response, and suppress humoral immune responses. The antiinflammatory actions of glucocorticoids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Ciclesonide reduces inflammatory reaction by limiting the capillary dilatation and permeability of the vascular structures. These compounds restrict the accumulation of polymorphonuclear leukocytes and macrophages and reduce the release of vasoactive kinins. Recent research suggests that corticosteroids may inhibit the release of arachidonic acid from phospholipids, thereby reducing the formation of prostaglandins. Ciclesonide is a glucocorticoid receptor agonist. On binding, the corticoreceptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing an increase or decrease in expression of specific target genes, including suppression of IL2 (interleukin 2) expression.
Leptomycin B
5
5 is a member of the class of compounds known as diterpene lactones. Diterpene lactones are diterpenoids containing a lactone moiety. 5 is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 5 can be found in roman camomile, which makes 5 a potential biomarker for the consumption of this food product. 5 is a non-carcinogenic (not listed by IARC) potentially toxic compound. 5 (five ) is a number, numeral, and glyph. It is the natural number following 4 and preceding 6 . Manganese mainly affects the nervous system and may cause behavioral changes and other nervous system effects, which include movements that may become slow and clumsy. This combination of symptoms when sufficiently severe is referred to as ‚Äúmanganism‚Äù (L228) (T3DB). 5 is a member of the class of compounds known as diterpene lactones. Diterpene lactones are diterpenoids containing a lactone moiety. 5 is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 5 can be found in roman camomile, which makes 5 a potential biomarker for the consumption of this food product. 5 is a non-carcinogenic (not listed by IARC) potentially toxic compound. 5 (five ) is a number, numeral, and glyph. It is the natural number following 4 and preceding 6 . Manganese mainly affects the nervous system and may cause behavioral changes and other nervous system effects, which include movements that may become slow and clumsy. This combination of symptoms when sufficiently severe is referred to as “manganism” (L228) (T3DB).
15beta,16beta-Isopropylidenedioxy-5alpha-cholest-3beta,4beta,6alpha,7alpha,8beta,26-hexaol
11-Cinnamoyl,12-Ac- Condurangamine B|condurangogenin C
3-O-(2E ,4E-Decadienoyl)-20-O-acetylingenol
22beta-isobutyryloxy-3-oxoolean-12-en-28-oic acid|lantadene D
Leptomycin B
A leptomycin having a (2E,10E,12E,16Z,18E)-double bond configuration as well as an ethyl substituent at position 17. D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D000970 - Antineoplastic Agents
20-O-acetyl-[5-O-(2E,4Z)-decadienoyl]-ingenol|5-O-(2E,4Z-decadienoyl)-20-O-acetylingenol
16-acetoxy-22alpha-hydroxy-29-nor-24-methyl-6,7-epoxycycloart-1,24(24a)-dien-3,23-dion-3,4-lactone|6,7-epoxyneomacrolactone
15??,16??-Isopropylidenedioxy-5??-cholest-3??,4??,6??,7??,8??,26-hexaol
ethyl 3,7,11,12,15,23-hexaoxo-5alpha-lanost-8-en-26-oate
22-Ketone,di-Ac -(3beta,22beta)-12-Oleanene-3,22,24-triol
1,3,7-tri-O-acetyl-14,15-deoxyhavanensin|14,15-deoxyhavanensin triacetate
7-oxo-8beta-D:C-friedo-olean-9(11)-ene-3alpha,29-diol diacetate
3alpha-Isobutyryloxy-2beta,15-dihydroxy-ent-labd-7-ene-2-O-beta-fucopyranoside
12b-O-[octa-2Z,4E-dienoyl]-13_-isobutyroyloxy-4b-deoxyphorbol
12-O-[octa-2Z,4E-dienoyl]-13-isobutyroyloxy-4-deoxyphorbol
His Lys Arg Thr
His Lys Thr Arg
His Arg Lys Thr
His Arg Thr Lys
His Thr Lys Arg
His Thr Arg Lys
Ile Pro Arg Arg
Ile Arg Pro Arg
Ile Arg Arg Pro
Lys His Arg Thr
Lys His Thr Arg
Lys Arg His Thr
Lys Arg Thr His
Lys Thr His Arg
Lys Thr Arg His
Leu Pro Arg Arg
Leu Arg Pro Arg
Leu Arg Arg Pro
Pro Ile Arg Arg
Pro Leu Arg Arg
Pro Arg Ile Arg
Pro Arg Leu Arg
Pro Arg Arg Ile
Pro Arg Arg Leu
Arg His Lys Thr
Arg His Thr Lys
Arg Ile Pro Arg
Arg Ile Arg Pro
Arg Lys His Thr
Arg Lys Thr His
Arg Leu Pro Arg
Arg Leu Arg Pro
Arg Pro Ile Arg
Arg Pro Leu Arg
Arg Pro Arg Ile
Arg Pro Arg Leu
Arg Arg Ile Pro
Arg Arg Leu Pro
Arg Arg Pro Ile
Arg Arg Pro Leu
Arg Thr His Lys
Arg Thr Lys His
Thr His Lys Arg
Thr His Arg Lys
Thr Lys His Arg
Thr Lys Arg His
Thr Arg His Lys
Thr Arg Lys His
(5Z,7E)-(1S,3R)-25,25-diphenyl-26,27-dinor-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5b,7a,12a)-2-(3-methoxyphenyl)-2-oxoethyl ester-7,12-dihydroxy-cholan-24-oic acid
1alpha,25-dihydroxy-25,25-diphenyl-26,27-dinorvitamin D3
Petromylidene A
1-(3-((((2S,3S,4R,5R)-5-(6-aMino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)Methyl)(isopropyl)aMino)propyl)-3-(4-(tert-butyl)phenyl)urea
Saridegib hydrochloride
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C188731 - Hedgehog Pathway Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor
N-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-fluorophenyl)urea
1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
N-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
1-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
N-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
N-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
1-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
1-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
N-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
N-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
1-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
N-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
N-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
N-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
N-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-fluorophenyl)urea
N-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
N-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-4-pyridinecarboxamide
1-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
O-[[[(R)-3-(Hexadecyloxy)-2-[acetylthio]propyl]oxy]phosphonyl]choline
2,3-Dihydroxypropyl (3-henicosoxy-2-hydroxypropyl) hydrogen phosphate
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] icosanoate
[1-Decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] decanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] hexadecanoate
[1-[(2-Acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] heptadecanoate
[1-[(2-Heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate
[1-[(2-Butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] pentadecanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] tetradecanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] undecanoate
[1-[(2-Hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tridecanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] decanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] decanoate
[1-Acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] heptadecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] tetradecanoate
[1-Butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] pentadecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] tridecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] dodecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] undecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] hexadecanoate
[3-hydroxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropyl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
[3-hydroxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-decanoyloxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-decanoyloxypropoxy]propyl]-trimethylazanium
[3-[2,3-bis[[(E)-dec-4-enoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium
[1-carboxy-3-[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium
[3-[3-acetyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
[3-[3-butanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
2-[carboxy-[2-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
1-tuberculosinyladenosine(1+)
An organic cation that is adenosine alkylated at position N1 by a tuberculosinyl group.
2-{3-[1-(3-hydroxy-5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-3a,9b-dimethyl-6'-oxo-1,2,3,4,7,8-hexahydrospiro[cyclopenta[a]naphthalene-6,3'-oxan]-7-yl}propan-2-yl acetate
methyl (6r)-6-[(1r,3ar,5ar,7r,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylidene-4-oxoheptanoate
{7,7,12,16-tetramethyl-15-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-5-oxo-6,19-dioxapentacyclo[9.8.0.0¹,¹⁸.0²,⁸.0¹²,¹⁶]nonadec-10-en-2-yl}methyl acetate
7,9-dimethoxy-n-{5-[(2-methoxy-2-oxoethyl)-c-hydroxycarbonimidoyl]pent-1-en-1-yl}-3,6,8-trimethyl-11-phenylundeca-2,4,10-trienimidic acid
(3r,6s)-6-[(1s,3r,8r,11s,12s,14s,15r,16r)-14-(acetyloxy)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methylhept-1-en-3-yl acetate
(2s,3r,4s,5s,6r)-2-{[(1e,3r,8r,9r,10r,11s,14s)-9-hydroxy-6-isopropyl-14-methoxy-14-(methoxymethyl)-3,10-dimethyltricyclo[9.3.0.0³,⁷]tetradeca-1,6-dien-8-yl]oxy}-6-(methoxymethyl)oxane-3,4,5-triol
methyl 2-hydroxy-6-pentadecyl-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate
{15-[1-(3-hydroxy-5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-7,7,12,16-tetramethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-1(18),10-dien-2-yl}methyl acetate
methyl (1r,3r,4r,7s,8s,11r,12s,13s,15s,16s,18r)-13-(acetyloxy)-3,7,12-trimethyl-4-[(2r)-6-methyl-5-methylideneheptan-2-yl]-19-oxahexacyclo[13.3.1.0³,⁷.0⁸,¹⁸.0¹¹,¹⁶.0¹⁶,¹⁸]nonadecane-12-carboxylate
3-propyl-6-[(2r,3s,4e,7e,10e,12e,15r,16r,17s,18e)-3,15,17-trihydroxy-4,8,10,12,16,18-hexamethylicosa-4,7,10,12,18-pentaen-2-yl]pyran-2-one
(4r,4as,6as,6br,8ar,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-4-[(2-methylpropanoyl)oxy]-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid
methyl 2-hydroxy-6-pentadecyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate
methyl 3-[7-(acetyloxy)-4,8-dimethyl-5-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradecan-13-yl]propanoate
(2r)-7-methoxy-2-methyl-6-[(1r,2s,6r)-3-methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-ene-1-carbonyl]-2-(4-methylpent-3-en-1-yl)chromen-5-ol
n-[14-(acetyloxy)-15-[1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethyltetracyclo[9.7.0.0³,⁸.0¹²,¹⁶]octadeca-1(18),2-dien-6-yl]-2-methylbut-2-enimidic acid
[(1r,3ar,5ar,5br,7ar,8r,9s,11ar,11br,13ar,13bs)-9-(acetyloxy)-3a,5a,5b,8,11a-pentamethyl-1-(3-oxoprop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-8-yl]methyl acetate
(2s,4s,7r,8s,9s,12r,13r,16r,17s,18r)-16-(acetyloxy)-2,9,13,17-tetramethyl-7-(4-methyl-2-oxopent-3-en-1-yl)-6-oxo-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-17-carboxylic acid
(1s,4s,5s,6r,9s,10r,12r,14r)-7-[(acetyloxy)methyl]-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-4-yl (2z,4e)-deca-2,4-dienoate
(e,2e,4e,6s,7s,8r,9s,10e)-7,9-dimethoxy-n-[(1z)-5-[(2-methoxy-2-oxoethyl)-c-hydroxycarbonimidoyl]pent-1-en-1-yl]-3,6,8-trimethyl-11-phenylundeca-2,4,10-trienimidic acid
(1r,3br,4r,5as,7r,9s,9as,9br,11as)-7,9-bis(acetyloxy)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
6-[(1s,3r,12s,14s,16r)-14-(acetyloxy)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methylhept-1-en-3-yl acetate
2,3-bis(2h-1,3-benzodioxol-5-ylmethyl)-4-hydroxybutyl dodecanoate
15β,16β-isopropylidenedioxy-5α-cholest-3β,4β,6α,7α,8β,26-hexaol
{"Ingredient_id": "HBIN001626","Ingredient_name": "15\u03b2,16\u03b2-isopropylidenedioxy-5\u03b1-cholest-3\u03b2,4\u03b2,6\u03b1,7\u03b1,8\u03b2,26-hexaol","Alias": "NA","Ingredient_formula": "C30H52O8","Ingredient_Smile": "CC(CCCC(C)C1C2C(C3C1(CCC4C3(C(C(C5C4(CCC(C5O)O)C)O)O)O)C)OC(O2)(C)C)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "11619","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
17-o-acetylmicrolepin
{"Ingredient_id": "HBIN002062","Ingredient_name": "17-o-acetylmicrolepin","Alias": "NA","Ingredient_formula": "C29H48O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "469","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-o-(2' e,4' e-decadienoyl)-20-o-acetylingenol
{"Ingredient_id": "HBIN008996","Ingredient_name": "3-o-(2' e,4' e-decadienoyl)-20-o-acetylingenol","Alias": "NA","Ingredient_formula": "C32H44O7","Ingredient_Smile": "CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)COC(=O)C)O)O)C","Ingredient_weight": "540.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14914","TCMID_id": "4819","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102004598","DrugBank_id": "NA"}
3-o-(2' e,4'z-decadienoyl)-20-o-acetylingenol
{"Ingredient_id": "HBIN008999","Ingredient_name": "3-o-(2' e,4'z-decadienoyl)-20-o-acetylingenol","Alias": "NA","Ingredient_formula": "C32H44O7","Ingredient_Smile": "CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)COC(=O)C)O)O)C","Ingredient_weight": "540.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14916","TCMID_id": "4821","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102004599","DrugBank_id": "NA"}
3-o-(2' e,4'z-decadienoyl)-5-o-acetylingenol
{"Ingredient_id": "HBIN009000","Ingredient_name": "3-o-(2' e,4'z-decadienoyl)-5-o-acetylingenol","Alias": "NA","Ingredient_formula": "C32H44O7","Ingredient_Smile": "CCCCCC=CC=CC(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)CO)OC(=O)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14915","TCMID_id": "4820","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6'-o-acetylmicrolepin
{"Ingredient_id": "HBIN012606","Ingredient_name": "6'-o-acetylmicrolepin","Alias": "NA","Ingredient_formula": "C29H48O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "468","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bisacutifolone a
{"Ingredient_id": "HBIN018595","Ingredient_name": "bisacutifolone a","Alias": "NA","Ingredient_formula": "C32H44O7","Ingredient_Smile": "CC1CCC2(C1(C(=O)C=C(C2C)C3CCC(C4=C3C(=O)C5(C(CCC5(C4C)C)C)C(=O)OC)O)C(=O)OC)C","Ingredient_weight": "540.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2429","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10506624","DrugBank_id": "NA"}
bisacutifolone b
{"Ingredient_id": "HBIN018598","Ingredient_name": "bisacutifolone b","Alias": "NA","Ingredient_formula": "C32H44O7","Ingredient_Smile": "CC1CCC2(C1(C(=O)C=C(C2C)C3CCC(C4=C3C(=O)C5(C(CCC5(C4C)C)C)C(=O)OC)O)C(=O)OC)C","Ingredient_weight": "540.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2432","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10626281","DrugBank_id": "NA"}